| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $784K | — |
| Gross Profit | -$41.8M | — |
| R&D Expense | $132.0M | -57.6% |
| SG&A Expense | $82.9M | -28.8% |
| Operating Income | -$286.1M | +36.6% |
| Pre-tax Income | -$431.6M | +21.8% |
| Income Tax | $109K | +78.7% |
| Net Income | -$431.7M | +21.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | -88.8% |
| Accounts Receivable | $7K | — |
| Inventory | $34.2M | +851.3% |
| Current Assets | $91.4M | +37.6% |
| Total Assets | $530.5M | +4.0% |
| Current Liabilities | $261.2M | -2.4% |
| Total Liabilities | $302.3M | -7.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$278.2M | +27.4% |
| Capital Expenditures | $31.1M | -74.8% |
| Investing Cash Flow | -$31.1M | +74.8% |
| Financing Cash Flow | $291.4M | +4436.3% |
| Free Cash Flow | -$309.3M | +38.9% |
| Stockholders' Equity |
| $228.2M |
| +24.9% |